 | • レポートコード：MRC23Q36445 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の動物アトピー性皮膚炎市場について調査・分析し、世界の動物アトピー性皮膚炎市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（経口、外用、注射）、用途別セグメント分析（動物病院、動物病院）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、GlenHaven、DermaPet、DVM Pharmaceuticals、Virbac、Enzo Life Sciences, Inc.、Pfizer Animal Health、Novartis Animal Health, Inc.、Eli Lilly and Company、Perrigo、Merck & Company、Zoetis Inc.、Toray Industries, Inc、Bayer Animal Health、Putney, Inc.、Dechra、Elanco、Kindred Biosciences、Nippon Zenyaku Kogyo Co., Ltd.などが含まれています。世界の動物アトピー性皮膚炎市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、動物アトピー性皮膚炎市場規模を推定する際に考慮しました。本レポートは、動物アトピー性皮膚炎の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、動物アトピー性皮膚炎に関するビジネス上の意思決定に役立てることを目的としています。 ・動物アトピー性皮膚炎市場の概要 - 動物アトピー性皮膚炎のタイプ別セグメント - 世界の動物アトピー性皮膚炎市場規模：タイプ別分析（経口、外用、注射） - 動物アトピー性皮膚炎の用途別セグメント - 世界の動物アトピー性皮膚炎市場規模：用途別分析（動物病院、動物病院） - 世界の動物アトピー性皮膚炎市場規模予測（2018年-2029年） ・動物アトピー性皮膚炎市場の成長トレンド - 動物アトピー性皮膚炎の地域別市場規模（2018年-2029年） - 動物アトピー性皮膚炎市場ダイナミクス - 動物アトピー性皮膚炎の業界動向 - 動物アトピー性皮膚炎市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：経口、外用、注射 - 世界の動物アトピー性皮膚炎のタイプ別市場規模（2018年-2023年） - 世界の動物アトピー性皮膚炎のタイプ別市場規模（2024年-2029年） ・用途別セグメント：動物病院、動物病院 - 世界の動物アトピー性皮膚炎の用途別市場規模（2018年-2023年） - 世界の動物アトピー性皮膚炎の用途別市場規模（2024年-2029年） ・動物アトピー性皮膚炎の地域別市場規模 - 北米の動物アトピー性皮膚炎市場規模（2018年-2029年） - アメリカの動物アトピー性皮膚炎市場規模（2018年-2029年） - ヨーロッパの動物アトピー性皮膚炎市場規模（2018年-2029年） - アジア太平洋の動物アトピー性皮膚炎市場規模（2018年-2029年） - 中国の動物アトピー性皮膚炎市場規模（2018年-2029年） - 日本の動物アトピー性皮膚炎市場規模（2018年-2029年） - 韓国の動物アトピー性皮膚炎市場規模（2018年-2029年） - インドの動物アトピー性皮膚炎市場規模（2018年-2029年） - オーストラリアの動物アトピー性皮膚炎市場規模（2018年-2029年） - 中南米の動物アトピー性皮膚炎市場規模（2018年-2029年） - 中東・アフリカの動物アトピー性皮膚炎市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 GlenHaven、DermaPet、DVM Pharmaceuticals、Virbac、Enzo Life Sciences, Inc.、Pfizer Animal Health、Novartis Animal Health, Inc.、Eli Lilly and Company、Perrigo、Merck & Company、Zoetis Inc.、Toray Industries, Inc、Bayer Animal Health、Putney, Inc.、Dechra、Elanco、Kindred Biosciences、Nippon Zenyaku Kogyo Co., Ltd. ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Veterinary Atopic Dermatitis market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Veterinary Atopic Dermatitis is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Veterinary Atopic Dermatitis is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Veterinary Atopic Dermatitis in Veterinary Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Veterinary Atopic Dermatitis include GlenHaven, DermaPet, DVM Pharmaceuticals, Virbac, Enzo Life Sciences, Inc., Pfizer Animal Health, Novartis Animal Health, Inc., Eli Lilly and Company and Perrigo, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Veterinary Atopic Dermatitis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Atopic Dermatitis.
The Veterinary Atopic Dermatitis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Veterinary Atopic Dermatitis market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Atopic Dermatitis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
GlenHaven
DermaPet
DVM Pharmaceuticals
Virbac
Enzo Life Sciences, Inc.
Pfizer Animal Health
Novartis Animal Health, Inc.
Eli Lilly and Company
Perrigo
Merck & Company
Zoetis Inc.
Toray Industries, Inc
Bayer Animal Health
Putney, Inc.
Dechra
Elanco
Kindred Biosciences
Nippon Zenyaku Kogyo Co., Ltd.
Segment by Type
Oral
External Use
Injection
Segment by Application
Veterinary Hospital
Veterinary Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Atopic Dermatitis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Veterinary Atopic Dermatitis Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 External Use
1.2.4 Injection
1.3 Market by Application
1.3.1 Global Veterinary Atopic Dermatitis Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Veterinary Hospital
1.3.3 Veterinary Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Atopic Dermatitis Market Perspective (2018-2029)
2.2 Veterinary Atopic Dermatitis Growth Trends by Region
2.2.1 Global Veterinary Atopic Dermatitis Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Veterinary Atopic Dermatitis Historic Market Size by Region (2018-2023)
2.2.3 Veterinary Atopic Dermatitis Forecasted Market Size by Region (2024-2029)
2.3 Veterinary Atopic Dermatitis Market Dynamics
2.3.1 Veterinary Atopic Dermatitis Industry Trends
2.3.2 Veterinary Atopic Dermatitis Market Drivers
2.3.3 Veterinary Atopic Dermatitis Market Challenges
2.3.4 Veterinary Atopic Dermatitis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Veterinary Atopic Dermatitis Players by Revenue
3.1.1 Global Top Veterinary Atopic Dermatitis Players by Revenue (2018-2023)
3.1.2 Global Veterinary Atopic Dermatitis Revenue Market Share by Players (2018-2023)
3.2 Global Veterinary Atopic Dermatitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Veterinary Atopic Dermatitis Revenue
3.4 Global Veterinary Atopic Dermatitis Market Concentration Ratio
3.4.1 Global Veterinary Atopic Dermatitis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary Atopic Dermatitis Revenue in 2022
3.5 Veterinary Atopic Dermatitis Key Players Head office and Area Served
3.6 Key Players Veterinary Atopic Dermatitis Product Solution and Service
3.7 Date of Enter into Veterinary Atopic Dermatitis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary Atopic Dermatitis Breakdown Data by Type
4.1 Global Veterinary Atopic Dermatitis Historic Market Size by Type (2018-2023)
4.2 Global Veterinary Atopic Dermatitis Forecasted Market Size by Type (2024-2029)
5 Veterinary Atopic Dermatitis Breakdown Data by Application
5.1 Global Veterinary Atopic Dermatitis Historic Market Size by Application (2018-2023)
5.2 Global Veterinary Atopic Dermatitis Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Veterinary Atopic Dermatitis Market Size (2018-2029)
6.2 North America Veterinary Atopic Dermatitis Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Veterinary Atopic Dermatitis Market Size by Country (2018-2023)
6.4 North America Veterinary Atopic Dermatitis Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Veterinary Atopic Dermatitis Market Size (2018-2029)
7.2 Europe Veterinary Atopic Dermatitis Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Veterinary Atopic Dermatitis Market Size by Country (2018-2023)
7.4 Europe Veterinary Atopic Dermatitis Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Atopic Dermatitis Market Size (2018-2029)
8.2 Asia-Pacific Veterinary Atopic Dermatitis Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Veterinary Atopic Dermatitis Market Size by Region (2018-2023)
8.4 Asia-Pacific Veterinary Atopic Dermatitis Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Veterinary Atopic Dermatitis Market Size (2018-2029)
9.2 Latin America Veterinary Atopic Dermatitis Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Veterinary Atopic Dermatitis Market Size by Country (2018-2023)
9.4 Latin America Veterinary Atopic Dermatitis Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Atopic Dermatitis Market Size (2018-2029)
10.2 Middle East & Africa Veterinary Atopic Dermatitis Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Veterinary Atopic Dermatitis Market Size by Country (2018-2023)
10.4 Middle East & Africa Veterinary Atopic Dermatitis Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlenHaven
11.1.1 GlenHaven Company Detail
11.1.2 GlenHaven Business Overview
11.1.3 GlenHaven Veterinary Atopic Dermatitis Introduction
11.1.4 GlenHaven Revenue in Veterinary Atopic Dermatitis Business (2018-2023)
11.1.5 GlenHaven Recent Development
11.2 DermaPet
11.2.1 DermaPet Company Detail
11.2.2 DermaPet Business Overview
11.2.3 DermaPet Veterinary Atopic Dermatitis Introduction
11.2.4 DermaPet Revenue in Veterinary Atopic Dermatitis Business (2018-2023)
11.2.5 DermaPet Recent Development
11.3 DVM Pharmaceuticals
11.3.1 DVM Pharmaceuticals Company Detail
11.3.2 DVM Pharmaceuticals Business Overview
11.3.3 DVM Pharmaceuticals Veterinary Atopic Dermatitis Introduction
11.3.4 DVM Pharmaceuticals Revenue in Veterinary Atopic Dermatitis Business (2018-2023)
11.3.5 DVM Pharmaceuticals Recent Development
11.4 Virbac
11.4.1 Virbac Company Detail
11.4.2 Virbac Business Overview
11.4.3 Virbac Veterinary Atopic Dermatitis Introduction
11.4.4 Virbac Revenue in Veterinary Atopic Dermatitis Business (2018-2023)
11.4.5 Virbac Recent Development
11.5 Enzo Life Sciences, Inc.
11.5.1 Enzo Life Sciences, Inc. Company Detail
11.5.2 Enzo Life Sciences, Inc. Business Overview
11.5.3 Enzo Life Sciences, Inc. Veterinary Atopic Dermatitis Introduction
11.5.4 Enzo Life Sciences, Inc. Revenue in Veterinary Atopic Dermatitis Business (2018-2023)
11.5.5 Enzo Life Sciences, Inc. Recent Development
11.6 Pfizer Animal Health
11.6.1 Pfizer Animal Health Company Detail
11.6.2 Pfizer Animal Health Business Overview
11.6.3 Pfizer Animal Health Veterinary Atopic Dermatitis Introduction
11.6.4 Pfizer Animal Health Revenue in Veterinary Atopic Dermatitis Business (2018-2023)
11.6.5 Pfizer Animal Health Recent Development
11.7 Novartis Animal Health, Inc.
11.7.1 Novartis Animal Health, Inc. Company Detail
11.7.2 Novartis Animal Health, Inc. Business Overview
11.7.3 Novartis Animal Health, Inc. Veterinary Atopic Dermatitis Introduction
11.7.4 Novartis Animal Health, Inc. Revenue in Veterinary Atopic Dermatitis Business (2018-2023)
11.7.5 Novartis Animal Health, Inc. Recent Development
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Detail
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Veterinary Atopic Dermatitis Introduction
11.8.4 Eli Lilly and Company Revenue in Veterinary Atopic Dermatitis Business (2018-2023)
11.8.5 Eli Lilly and Company Recent Development
11.9 Perrigo
11.9.1 Perrigo Company Detail
11.9.2 Perrigo Business Overview
11.9.3 Perrigo Veterinary Atopic Dermatitis Introduction
11.9.4 Perrigo Revenue in Veterinary Atopic Dermatitis Business (2018-2023)
11.9.5 Perrigo Recent Development
11.10 Merck & Company
11.10.1 Merck & Company Company Detail
11.10.2 Merck & Company Business Overview
11.10.3 Merck & Company Veterinary Atopic Dermatitis Introduction
11.10.4 Merck & Company Revenue in Veterinary Atopic Dermatitis Business (2018-2023)
11.10.5 Merck & Company Recent Development
11.11 Zoetis Inc.
11.11.1 Zoetis Inc. Company Detail
11.11.2 Zoetis Inc. Business Overview
11.11.3 Zoetis Inc. Veterinary Atopic Dermatitis Introduction
11.11.4 Zoetis Inc. Revenue in Veterinary Atopic Dermatitis Business (2018-2023)
11.11.5 Zoetis Inc. Recent Development
11.12 Toray Industries, Inc
11.12.1 Toray Industries, Inc Company Detail
11.12.2 Toray Industries, Inc Business Overview
11.12.3 Toray Industries, Inc Veterinary Atopic Dermatitis Introduction
11.12.4 Toray Industries, Inc Revenue in Veterinary Atopic Dermatitis Business (2018-2023)
11.12.5 Toray Industries, Inc Recent Development
11.13 Bayer Animal Health
11.13.1 Bayer Animal Health Company Detail
11.13.2 Bayer Animal Health Business Overview
11.13.3 Bayer Animal Health Veterinary Atopic Dermatitis Introduction
11.13.4 Bayer Animal Health Revenue in Veterinary Atopic Dermatitis Business (2018-2023)
11.13.5 Bayer Animal Health Recent Development
11.14 Putney, Inc.
11.14.1 Putney, Inc. Company Detail
11.14.2 Putney, Inc. Business Overview
11.14.3 Putney, Inc. Veterinary Atopic Dermatitis Introduction
11.14.4 Putney, Inc. Revenue in Veterinary Atopic Dermatitis Business (2018-2023)
11.14.5 Putney, Inc. Recent Development
11.15 Dechra
11.15.1 Dechra Company Detail
11.15.2 Dechra Business Overview
11.15.3 Dechra Veterinary Atopic Dermatitis Introduction
11.15.4 Dechra Revenue in Veterinary Atopic Dermatitis Business (2018-2023)
11.15.5 Dechra Recent Development
11.16 Elanco
11.16.1 Elanco Company Detail
11.16.2 Elanco Business Overview
11.16.3 Elanco Veterinary Atopic Dermatitis Introduction
11.16.4 Elanco Revenue in Veterinary Atopic Dermatitis Business (2018-2023)
11.16.5 Elanco Recent Development
11.17 Kindred Biosciences
11.17.1 Kindred Biosciences Company Detail
11.17.2 Kindred Biosciences Business Overview
11.17.3 Kindred Biosciences Veterinary Atopic Dermatitis Introduction
11.17.4 Kindred Biosciences Revenue in Veterinary Atopic Dermatitis Business (2018-2023)
11.17.5 Kindred Biosciences Recent Development
11.18 Nippon Zenyaku Kogyo Co., Ltd.
11.18.1 Nippon Zenyaku Kogyo Co., Ltd. Company Detail
11.18.2 Nippon Zenyaku Kogyo Co., Ltd. Business Overview
11.18.3 Nippon Zenyaku Kogyo Co., Ltd. Veterinary Atopic Dermatitis Introduction
11.18.4 Nippon Zenyaku Kogyo Co., Ltd. Revenue in Veterinary Atopic Dermatitis Business (2018-2023)
11.18.5 Nippon Zenyaku Kogyo Co., Ltd. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details